Skip to content

Above 180/120? See warning signs

SevereHypertension

Microalbuminuria Can Predict Complications in Hypertension

Severe Hypertension NetworkPublished May 9, 20102 min read

Key points

  • Microalbuminuria independently predicts higher risk of renal and cardiovascular complications in patients with primary hypertension but without diabetes, according to research published online April 29 in the Clinical Journal of the American Society of Nephrology.
  • After adjustment for baseline covariates, microalbuminuria was still significantly associated with cardiorenal events (RR, 2.58) and chronic renal insufficiency (RR, 12.75).
  • Francesca Viazzi, M.D., of the University of Genoa in Italy, and colleagues conducted a study of 917 patients with hypertension and without diabetes at baseline, following them for a median of 11.8 years.
  • “Patients with microalbuminuria should be aggressively targeted for renal and cardiovascular risk factor reduction, although further research is warranted to determine whether specific treatment would help to improve outcomes, as already reported for patients with diabetes,” the authors write.

Microalbuminuria independently predicts higher risk of renal and cardiovascular complications in patients with primary hypertension but without diabetes, according to research published online April 29 in the Clinical Journal of the American Society of Nephrology.

Francesca Viazzi, M.D., of the University of Genoa in Italy, and colleagues conducted a study of 917 patients with hypertension and without diabetes at baseline, following them for a median of 11.8 years. Urinary albumin-to-creatinine ratio (ACR) was used to determine microalbuminuria based on gender-specific cut-points (ACR of at least 22 mg/g in men and at least 31 mg/g in women).

The researchers found that microalbuminuria at baseline was associated with an increased risk for developing chronic renal insufficiency (relative risk [RR], 7.61), as well as cardiovascular events (composite of fatal and nonfatal cardiac and cerebrovascular events; RR, 2.11), and cardiorenal events (composite of former end points; RR 3.21).

After adjustment for baseline covariates, microalbuminuria was still significantly associated with cardiorenal events (RR, 2.58) and chronic renal insufficiency (RR, 12.75).

“Patients with microalbuminuria should be aggressively targeted for renal and cardiovascular risk factor reduction, although further research is warranted to determine whether specific treatment would help to improve outcomes, as already reported for patients with diabetes,” the authors write.

– –

Francesca Viazzi, Giovanna Leoncini, Novella Conti, Cinzia Tomolillo, Giovanna Giachero, Marina Vercelli, Giacomo Deferrari, and Roberto Pontremoli

* Department of Cardionephrology and Department of Internal Medicine, University of Genoa, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy; Registro Tumori della Regione Liguria, SS Epidemiologia Descrittiva, IST-Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy; and DISSAL Dipartimento Scienze della Salute, Universit?? di Genova, Genoa, Italy


Published ahead of print on April 29, 2010
Clinical Journal of the American Society of Nephrology

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. A reading above 180/120 with chest pain, shortness of breath, weakness or vision changes is an emergency: call 911 or your local emergency number.

Hypertensive crisis

Above 180/120? Know when it’s an emergency.

Wait five minutes and measure again. If your reading is still this high and you have any of these symptoms, call 911 or your local emergency number. Don’t wait to see if it comes down on its own.

  • Chest pain
  • Shortness of breath
  • Back pain
  • Numbness or weakness
  • Change in vision
  • Difficulty speaking

No symptoms but still above 180/120 after a second reading? Contact your doctor straight away. Outside the US, call your local emergency number.